OakChart

Conmed Corp

CNMDHealthcare·Medical Devices·USA·Small·NYSE·Nov 11 • 3:59 PM ET

50.77-0.44 (-0.86%)
2026-11-12 05:48 CET
Market cap
1,513.11 USD m
Revenue, TTM
1,370.87 USD m
Net income, TTM
73.43 USD m
Free cash flow, TTM
132.69 USD m
EPS diluted, TTM
2.41
P/E
21.03
Compare

Price

CNMD against its 20, 50 and 200-day averages
2050200miss
40.0050.001.2M2.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CNMDclose 50.7720-day 48.4850-day 47.12200-day 41.7850.7752w high52w low

7.4% under the 52-week high of 54.80 on 5 Nov 2026. 52-week low 31.44 on 22 Jun 2026. Last 15 sessions, 26.0% high to low

Volume 0.56× normal · the line is the 50-bar volume average

Profile

CNMD
52-week range, 83% of the way up
31.4454.80

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

IndexRUT
Employees3900
IPOJul 23, 1987
Beta0.87
ATR, 14d2.14
Rel volume0.56
Short float6.27%
Insider own0.39%
Inst own112.01%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.51B
Enterprise Value2.28B
Income73.43M
Sales1.37B
Book/sh35.49
Cash/sh1.61
Dividend Est.-
Dividend TTM-
Dividend Ex-DateSep 15, 2025
Dividend Gr. 3/5Y- -
Payout39.72%
Employees3900
IPOJul 23, 1987

Ratios

P/E21.03
Forward P/E10.69
PEG2.37
P/S1.10
P/B1.43
P/C31.54
P/FCF11.40
EV/EBITDA30.01
EV/Sales1.66
Quick Ratio0.70
Current Ratio1.49
Debt/Eq0.77
LT Debt/Eq0.60
Option/ShortYes / Yes

Earnings

EPS (ttm)2.41
EPS next Y4.75
EPS next Q1.26
EPS this Y-0.37%
EPS next Y3.84%
EPS next 5Y4.51%
EPS past 3/5Y- 36.14%
Sales past 3/5Y10.08% 9.82%
EPS Y/Y TTM16.93%
Sales Y/Y TTM1.93%
EPS Q/Q613.46%
Sales Q/Q-0.88%
EarningsOct 28 AMC
EPS/Sales Surpr.3.70% -0.22%

Ownership

Insider Own0.39%
Insider Trans0.00%
Inst Own112.01%
Inst Trans0.50%
ROA3.17%
ROE7.10%
ROIC4.33%
Gross Margin44.85%
Oper. Margin1.59%
Profit Margin5.36%
SMA204.72%
SMA507.74%
SMA20021.52%
Trades-

Technical

Shs Outstand29.87M
Shs Float29.69M
Short Float6.27%
Short Ratio5.10
Short Interest1.86M
52W High54.80 -7.35%
52W Low31.44 61.48%
Volatility3.28% 4.58%
ATR (14)2.14
RSI (14)57.59
Beta0.87
Rel Volume0.56
Avg Volume365.20K
Volume204,887

Performance

Perf Week-5.39%
Perf Month11.46%
Perf Quarter1.91%
Perf Half Y42.81%
Perf YTD25.05%
Perf Year13.55%
Perf 3Y-48.47%
Perf 5Y-66.40%
Perf 10Y13.83%
Recom3.14
Target Price46.83
Prev Close51.21
Price50.77
Change %-0.86%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 09, 2026InitiatedBBMO Capital MarketsMarket Perform$36-29.1%
Jun 29, 2026DowngradeBBofA SecuritiesNeutral → Underperform$40-21.2%
Mar 17, 2026DowngradePPiper SandlerOverweight → Neutral$39-23.2%
Jun 12, 2025DowngradeNNeedhamBuy → Hold
Apr 28, 2025DowngradeSStifelBuy → Hold$55+8.3%
Feb 06, 2025DowngradeJJP MorganOverweight → Neutral$85 → $70+37.9%
Feb 01, 2024ReiteratedNNeedhamBuy$119 → $129+154.1%
May 22, 2023InitiatedCCL KingBuy$140+175.8%
Mar 27, 2023UpgradeKKeyBanc Capital MarketsSector Weight → Overweight$124+144.2%
Mar 21, 2023InitiatedWWells FargoEqual Weight$96+89.1%

Peers

Mkt cap
TickerCompanyMkt cap
SNNSmith & Nephew plc ADR12.99B
SYKStryker Corp121.36B
ENOVEnovis Corp1.65B
ZBHZimmer Biomet Holdings Inc20.34B
IARTIntegra Lifesciences Holdings Corp1.15B
MDTMedtronic Plc129.98B
TFXTeleflex Incorporated6.20B
JNJJohnson & Johnson675.03B
ANIKAnika Therapeutics Inc186.86M
ISRGIntuitive Surgical Inc155.83B

Insider trading

12 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Foust Hollie KGeneral Counsel & Corp SecNov 04 '26Option Exercise0.004,00006,886Nov 06 03:02 PM
Kelderman KimDirectorSep 08 '26Option Exercise0.005000500Sep 10 03:13 PM
Bronson David M.DirectorJun 02 '26Option Exercise0.00668017,909Jun 03 04:22 PM
Council LaVerne HDirectorJun 02 '26Option Exercise0.0066804,716Jun 03 04:18 PM
Farkas CharlesDirectorJun 02 '26Option Exercise0.00668015,527Jun 03 04:12 PM
Kaye MarkDirectorJun 02 '26Option Exercise0.006680820Jun 03 04:10 PM
Schwarzentraub Barbara JDirectorJun 02 '26Option Exercise0.0066805,012Jun 03 04:07 PM
Lalomia BrentExecutive VP RA, QAMar 06 '26Option Exercise0.00750941Mar 10 02:40 PM
Kaye MarkDirectorFeb 24 '26Option Exercise0.001520152Feb 26 09:23 AM
Glaze RichardChief Information OfficerNov 21 '25Sale41.2125710,5910Nov 24 01:18 PM
Glaze RichardChief Information OfficerNov 20 '25Option Exercise0.003750375Nov 21 03:39 PM
Glaze RichardOfficerNov 21 '25Proposed Sale41.2125710,591Nov 21 09:40 AM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-281.0401.0030.660335.56336.287
2026Q22026-07-291.3801.1100.766343.49337.67
2026Q12026-04-290.8900.8190.452317.05310.646
2025Q42026-01-281.4301.3240.539373.2366.886
2025Q32025-11-051.0801.0630.092337.93336.395
2025Q22025-07-301.1501.1230.690342.35338.356
2025Q12025-04-300.9500.8110.194321.26313.47
2024Q42025-02-051.3401.2031.084345.943417
2024Q32024-10-301.0501.0231.574316.7317.788
2024Q22024-07-310.9800.9100.964332.1334.398
2024Q12024-04-240.7900.7380.630312.27306.758
2023Q42024-01-311.0601.1111.050327.05332.218
2023Q32023-10-250.9000.8390.500304.58301.428
2023Q22023-07-260.8300.7940.432317.65306.159
2023Q12023-04-260.6600.5980.058295.47266.638
2022Q42023-02-020.4200.9040.860250.87302.487

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY2.6402.6360.970955.1955.2
2020FY2.1802.1010.323862.46872.65
2021FY3.2103.1711.9411,0111,013
2022FY2.6503.120-2.6831,0451,097
2023FY3.4503.5002.0431,2451,250
2024FY4.1704.0274.2511,3071,302
2025FY4.5904.5001.5101,3751,368
2026FY-4.573--1,363
2027FY-4.749--1,426
2028FY-5.240--1,502
2029FY-5.744--1,577
2030FY-6.708--1,635

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-29702366.55365.3367
2026Q4S2026-10-28700368.99367371.65
2026Q4S2026-10-13700368.99367371.65
2026Q4S2026-07-30703368.99367371.65
2026Q4S2026-07-14700372.24369.6377.5
2026Q4S2026-07-10711372.24369.6377.5
2026Q4S2026-07-07711372.23369.6377.5
2026Q4S2026-04-30611372.07369.6377.5
2026Q4S2026-04-14600372.69368.81378.3
2026Q4S2026-02-05611372.69368.81378.3
2026Q4S2026-01-29511371.57368.81378.2
2026Q4S2026-01-20201373.89362.8384.98
2026Q4S2025-12-04202373.89362.8384.98
2026Q4S2025-11-11201386.28384.98387.58

Estimate history

EPS, annual1.971.4140.970.3231.941-2.6832.0434.2511.5112.4142
Period201720182019202020212022202320242025TTM
EPS, quarterly1.5741.0840.1940.690.0920.5390.4520.7660.657
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual795.674858.721947.128860.4621016.0561030.3871240.9541302.731374.4951370.87
Period201720182019202020212022202320242025TTM
Sales, quarterly316.431343.919319.405343.038338.579373.474318.046343.758335.587
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual27.96128.13228.42228.88929.37330.48830.76530.90130.97129.869
Period201720182019202020212022202320242025MRQ
Shares, quarterly30.88530.90130.9330.94630.95530.97130.14429.98729.869
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,370.871,374.491,302.731,240.951,030.391,016.06860.46947.13858.72
Cost of Goods Sold Incl. D&A756.00649.12608.16597.89502.37477.31417.99459.13390.52
Gross Profit614.87725.38694.57643.07528.02538.75442.48488.00468.20
Selling, General and Administrative Excl. Other593.12584.24530.35512.28444.39422.32365.70399.01381.82
Research and Development62.3255.8854.4352.6047.1543.5640.4745.4628.48
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income21.75141.13164.22130.7983.63116.4276.7888.9986.38
Interest Expense33.4531.0937.3039.7728.9135.4844.0542.7020.65
Unusual Expense30.4138.34-30.6918.81141.613.8232.1522.3916.08
Net Income Before Taxes104.9671.12163.0380.83-70.8673.111.6031.2350.65
Income Taxes31.5324.0630.6116.379.7210.56-7.912.609.80
Consolidated Net Income73.4347.05132.4264.46-80.5862.549.5228.6240.85
Net Income From Continuing Operations73.4347.05132.4264.46-80.5862.549.5228.6240.85
Net Income73.4347.05132.4264.46-80.5862.549.5228.6240.85
EPS (Recurring)3.142.373.562.460.622.021.091.501.80
EPS (Basic, Before Extraordinaries)2.421.524.292.10-2.682.140.331.011.45
EPS (Diluted)2.411.514.252.04-2.681.940.320.971.41
EBITDA76.02193.47215.53182.19133.38166.22129.02139.98148.18
Non-Operating Income (Expense)147.07-0.595.418.6316.02-4.011.027.321.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense17.0824.6221.6620.2617.9312.449.918.987.93
Price To Earnings Ratio21.0321.0316.2259.21-73.28402.01117.3745.47
Price To Sales Ratio1.020.921.642.782.584.493.843.482.16
Gross Margin44.8552.7753.3251.8251.2453.0251.4251.5254.52
Operating Margin1.5910.2712.6110.548.1211.468.929.4010.06
Net Margin5.363.4210.175.19-7.826.161.113.024.76
Shares Outstanding29.8730.9730.9030.7730.4929.3728.8928.4228.13
Market Capitalization1,513.111,513.112,114.173,367.672,701.964,146.073,203.383,173.621,805.88

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue335.59343.76318.05373.47338.58343.04319.40343.92
Cost of Goods Sold Incl. D&A300.26154.26141.32160.15180.62162.52151.52161.16
Gross Profit35.32189.49176.73213.33157.96180.52167.89182.76
Selling, General and Administrative Excl. Other144.66153.00149.01146.45138.56138.80156.41128.98
Research and Development15.5915.5016.3314.9013.9014.1412.9513.18
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-109.3336.4927.7266.8719.4041.7211.4853.78
Interest Expense11.137.887.067.377.617.828.298.86
Unusual Expense-0.10-2.012.2230.296.983.08-3.313.06
Net Income Before Taxes26.0131.3518.3629.254.2729.927.6743.64
Income Taxes6.218.284.5312.511.418.501.649.89
Consolidated Net Income19.8023.0713.8316.742.8621.426.0433.75
Net Income From Continuing Operations19.8023.0713.8316.742.8621.426.0433.75
Net Income19.8023.0713.8316.742.8621.426.0433.75
EPS (Recurring)0.650.720.501.220.250.760.121.15
EPS (Basic, Before Extraordinaries)0.660.770.450.540.090.690.191.09
EPS (Diluted)0.660.770.450.540.090.690.191.08
EBITDA-98.1147.8140.5985.7232.4854.8824.4171.78
Non-Operating Income (Expense)146.380.73-0.080.04-0.54-0.901.171.78
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.674.134.353.933.623.8710.954.92
Price To Earnings Ratio21.0318.4623.3419.7113.2813.6514.2016.22
Price To Sales Ratio1.020.720.790.921.091.221.441.64
Gross Margin10.5355.1255.5757.1246.6552.6252.5653.14
Operating Margin-32.5810.628.7117.915.7312.163.5915.64
Net Margin5.906.714.354.480.846.241.899.81
Shares Outstanding29.8729.9930.1430.9730.9630.9530.9330.90
Market Capitalization1,513.11985.471,090.271,257.301,455.811,611.351,866.582,114.17

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments40.8224.4624.3028.9420.8527.3625.8617.5132.62
Short Term Receivables247.83237.73242.28191.34183.88177.15189.10181.55167.04
Inventories355.54346.72318.32332.32231.64194.87164.62154.60141.44
Other Current Assets28.6731.1030.7528.6223.7517.2817.7920.6915.69
Total Current Assets672.86640.01615.65581.23460.12416.65397.36374.35356.78
Net Property, Plant & Equipment162.32155.63137.33133.32128.29133.07141.98113.25116.23
Total Investments and Advances0.000.260.000.000.000.000.000.000.00
Intangible Assets1,389.061,423.021,456.331,497.231,088.581,119.981,150.84813.63816.89
Deferred Tax Assets13.3111.0711.219.659.666.845.665.164.72
Other Assets88.2076.2579.5076.1779.3775.1379.2562.7563.33
Total Assets2,325.752,306.252,300.022,297.591,766.021,751.671,775.101,369.141,357.96
Short Term Debt Incl. Current Port. of LT Debt9.328.818.2276.6712.2525.8820.8618.3414.70
Accounts Payable93.65102.2588.2273.3958.2053.3155.9753.5042.04
Other Current Liabilities212.07167.07214.29146.49126.20111.01111.2589.1193.26
Total Current Liabilities315.04278.13310.73296.55196.65190.20188.09160.94150.00
Long Term Debt878.16938.35983.04996.84672.41749.98772.31438.56471.74
Provision for Risks Charges0.000.000.000.0016.1024.3016.7314.470.01
Deferred Tax Liabilities79.5374.0860.9066.7268.5457.8874.4981.0677.67
Other Liabilities19.9253.01111.13191.9426.8920.2813.0211.8327.10
Total Liabilities1,292.651,343.571,465.801,552.05980.581,042.631,064.63706.87726.53
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,033.10962.68834.22745.54785.43709.04710.47662.27631.43
Total Shareholders Equity1,033.10962.68834.22745.54785.43709.04710.47662.27631.43
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,033.10962.68834.22745.54785.43709.04710.47662.27631.43
Total Liabilities & Stockholders Equity2,325.752,306.252,300.022,297.591,766.021,751.671,775.101,369.141,357.96
Book Value Per Share33.3631.1527.1224.4526.7424.5425.0023.5422.58
Tangible Book Value Per Share-11.49-14.90-20.22-24.66-10.32-14.22-15.49-5.38-6.63
Full-Time Employees3,9003,9004,0004,1003,8003,4003,3003,1003,100
Price to Book Ratio1.432.274.233.775.304.564.472.732.41
Return on Assets2.035.752.80-3.973.560.541.823.004.13
Return on Equity4.7214.748.16-10.538.371.344.176.329.16
Return on Invested Capital2.466.973.55-4.624.290.651.933.715.03
Quick Ratio1.011.050.960.841.161.171.241.371.44
Current Ratio2.142.301.981.962.342.192.112.332.38

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income73.4347.05132.4264.46-80.5862.549.5228.6240.85
Depreciation75.9274.2871.8671.8769.5270.7472.6272.3261.80
Other Funds (Non Cash)40.3357.28-9.7927.89141.1731.1826.5324.1514.25
Funds from Operations198.78182.14206.69164.93124.06167.4794.43118.78118.97
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-52.46-11.45-39.72-39.58-90.70-55.70-29.90-23.65-44.27
Income Taxes Payable--0.56-0.19-3.926.73-1.68-1.64-1.87-2.19
Cash from Operating Activities146.31170.69166.97125.3533.37111.7764.5395.1374.70
Capital Expenditures-13.62-19.81-13.08-19.03-21.79-14.87-13.01-20.07-16.51
Net Assets From Acquisitions0.000.000.000.00-227.740.00-3.85-367.600.00
Sale of Fixed Assets and Businesses22.310.000.000.000.000.003.230.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00-
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-1.15-1.150.00-1.000.000.000.000.000.00
Other Sources-0.850.000.000.000.000.000.000.000.00
Cash from Investing Activities6.69-20.96-13.08-20.03-249.53-14.87-13.64-387.66-16.51
Cash Dividends Paid-6.19-24.75-24.65-24.50-23.96-23.26-22.82-22.60-22.44
Change in Capital Stock-49.420.000.000.0072.000.000.0030.570.00
Repurchase of Common Pref Stock-49.420.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.0072.000.000.0030.570.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-36.36-77.48-72.30-88.00340.19-83.24-29.40346.64-29.04
Change in Long Term Debt-36.36-77.48-72.30-88.00340.19-83.24-29.40346.64-29.04
Issuance of Long Term Debt1,396.44717.77750.70692.001,238.17377.16195.85985.79152.09
Reduction of Long Term Debt-1,432.80-795.25-823.00-780.00-897.98-460.41-225.25-639.15-181.12
Net Financing Active Other Cash Flow-51.14-33.59-54.052.07-163.234.950.16-53.73-20.78
Other Financing Activities Uses-51.86-33.76-56.88-13.87-257.93-6.22-2.67-57.66-22.90
Cash from Financing Activities-143.11-135.82-151.00-110.43225.00-101.55-52.06300.88-72.27
Exchange Rate Effect-0.852.44-2.720.47-0.74-1.862.67-0.01-1.04
Net Change in Cash9.0416.360.16-4.658.10-6.511.508.35-15.11
Free Cash Flow132.69150.88153.88106.3211.5896.9051.5275.0758.19
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow11.0110.0316.5042.23-62.01114.9862.8751.88
Deferred Taxes & Investment Tax Credit-3.5212.200.70-6.043.00-14.23-6.312.06

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments47.9737.3335.0340.8238.9333.94
Short Term Receivables233.91239.77228.66247.83224.94234.15
Inventories362.83360.18366.11355.54364.36362.25
Other Current Assets37.3338.3940.7928.6733.9327.45
Total Current Assets682.04675.66670.59672.86662.16657.78
Net Property, Plant & Equipment108.77110.14111.96162.32112.04116.86
Total Investments and Advances0.441.370.660.000.000.00
Intangible Assets1,353.561,361.321,380.661,389.061,400.021,408.74
Deferred Tax Assets---13.31--
Other Assets159.66151.81151.0788.20148.27145.07
Total Assets2,304.462,300.312,314.942,325.752,322.492,328.46
Short Term Debt Incl. Current Port. of LT Debt180.11177.200.719.320.750.71
Accounts Payable98.50101.02105.4293.65107.09101.05
Other Current Liabilities180.36177.18186.59212.07206.87193.07
Total Current Liabilities458.96455.40292.72315.04314.70294.84
Long Term Debt635.76657.05860.16878.16853.01881.11
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities88.9684.5881.3879.5374.8669.82
Other Liabilities60.8661.8863.0219.9271.6679.82
Total Liabilities1,244.541,258.921,297.271,292.651,314.221,325.59
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,059.921,041.391,017.671,033.101,008.261,002.87
Total Shareholders Equity1,059.921,041.391,017.671,033.101,008.261,002.87
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,059.921,041.391,017.671,033.101,008.261,002.87
Total Liabilities & Stockholders Equity2,304.462,300.312,314.942,325.752,322.492,328.46
Book Value Per Share35.4934.7333.7633.3632.5732.41
Tangible Book Value Per Share-9.83-10.67-12.04-11.49-12.66-13.12
Full-Time Employees---3,900--
Price to Book Ratio1.430.971.061.251.451.65
Return on Assets3.172.442.382.032.764.78
Return on Equity7.105.535.504.726.6011.69
Return on Invested Capital1.171.360.740.880.151.14
Quick Ratio0.700.691.041.010.951.00
Current Ratio1.491.482.292.142.102.23

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income19.8023.0713.8316.742.8621.42
Depreciation19.1819.0518.8418.8518.6118.57
Other Funds (Non Cash)6.813.983.5825.967.204.86
Funds from Operations50.3948.2437.7862.3632.3546.53
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.98-11.15-24.31-16.0221.33-17.40
Cash from Operating Activities49.4137.0913.4746.3453.6929.13
Capital Expenditures-2.68-2.93-2.89-5.11-5.19-5.73
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.8114.507.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.00-1.150.000.00
Other Sources0.000.000.00-0.850.000.00
Cash from Investing Activities-1.8711.574.11-7.11-5.19-5.73
Cash Dividends Paid0.000.000.00-6.19-6.19-6.19
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-6.20-6.20-37.020.000.000.00
Repurchase of Common Pref Stock-6.20-6.20-37.020.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-18.64-22.7225.00-20.00-29.00-13.90
Change in Long Term Debt-18.64-22.7225.00-20.00-29.00-13.90
Issuance of Long Term Debt167.99861.45180.00187.00167.00197.77
Reduction of Long Term Debt-186.62-884.18-155.00-207.00-196.00-211.66
Net Financing Active Other Cash Flow-12.12-17.31-10.54-11.18-8.34-6.45
Other Financing Activities Uses-11.83-17.49-11.36-11.18-8.48-6.46
Cash from Financing Activities-36.96-46.23-22.55-37.37-43.52-26.53
Exchange Rate Effect0.06-0.13-0.810.030.021.57
Net Change in Cash10.642.30-5.791.894.99-1.55
Free Cash Flow46.7334.1610.5841.2248.5023.41
Price to Free Cash Flow11.018.0710.309.9911.7613.09

Revenue breakdown

General Surgery2024: 763.03M 2025: 800.13M
Orthopedic Surgery2024: 543.99M 2025: 574.60M
Americas (excluding the United States)2024: 121.04M 2025: 126.76M
Asia Pacific2024: 194.68M 2025: 208.72M
EMEA2024: 243.06M 2025: 264.65M
United States2024: 748.22M 2025: 774.59M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.27%1.9M29.7M385.17K
2026-10-156.41%1.9M29.8M420.84K
2026-09-306.55%2.0M29.8M504.76K
2026-09-157.17%2.1M29.8M560.58K
2026-08-317.59%2.3M29.8M600.78K
2026-08-147.78%2.3M29.8M623.36K
2026-07-317.49%2.2M29.8M619.64K
2026-07-157.77%2.3M30.0M585.56K
2026-06-308.45%2.5M30.0M496.10K
2026-06-157.18%2.2M30.0M450.40K
2026-05-297.81%2.3M30.0M428.72K
2026-05-157.65%2.3M30.0M442.61K
2026-04-308.28%2.5M29.9M461.75K
2026-04-157.71%2.3M30.0M507.71K
2026-03-317.29%2.2M30.6M548.44K
2026-03-137.37%2.3M30.6M568.86K
2026-02-277.90%2.4M30.6M605.31K
2026-02-136.71%2.1M30.6M613.00K
2026-01-307.56%2.3M30.0M615.93K
2026-01-157.74%2.3M30.0M551.53K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call17.5031.5035.200.006.3460.000.000.979-0.0900.004
call20.0029.0032.700.005.6390.000.000.976-0.0890.004
call22.5026.5030.2020.065.2871.000.000.973-0.0880.005
call25.0024.0027.700.004.7240.000.000.970-0.0870.005
call30.0019.0022.7015.153.6947.000.000.961-0.0830.007
call35.0014.0017.7012.202.8308.000.000.948-0.0790.008
call40.009.0012.707.332.07313.000.000.781-0.3640.023
call45.004.208.302.671.64713.000.000.706-0.3130.027
call50.001.003.204.000.8931720.000.570-0.2180.031
call55.000.003.600.451.5367.000.000.412-0.2650.031
call60.000.000.450.050.8437460.000.114-0.0730.015
call65.000.000.500.171.10847.000.000.092-0.0820.013
call70.000.003.400.001.3560.000.000.079-0.0890.012
call75.000.003.400.001.5680.000.000.070-0.0950.011
put17.500.003.400.003.9570.000.00-0.021-0.0880.004
put20.000.003.400.003.5000.000.00-0.024-0.0870.004
put22.500.003.400.253.1002.000.00-0.027-0.0860.005
put25.000.003.400.352.7422.000.00-0.030-0.0840.005
put30.000.003.400.252.1228.000.00-0.039-0.0800.007
put35.000.000.750.301.59054.000.00-0.052-0.0750.008
put40.000.003.400.102.73516.000.00-0.219-0.3600.023
put45.000.003.501.652.0142.000.00-0.294-0.3080.027
put50.000.004.200.001.4700.000.00-0.430-0.2120.031
put55.002.406.500.001.2390.000.00-0.588-0.2590.031
put60.007.3011.2010.001.5790.000.00-0.886-0.0670.015
put65.0012.3016.000.001.8590.000.00-0.909-0.0750.013
put70.0017.1021.000.002.1630.000.00-0.921-0.0810.012
put75.0022.1026.000.002.4320.000.00-0.930-0.0860.011

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-10-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-174Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-173Initial statement of beneficial ownership of securities2026-07-15SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-023Initial statement of beneficial ownership of securities2026-07-01SEC
2026-07-023Initial statement of beneficial ownership of securities2026-07-01SEC
2026-06-178-KCurrent report2026-06-17SEC
2026-06-1611-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-048-KCurrent report2026-06-03SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-033/A2026-06-01SEC
2026-06-033Initial statement of beneficial ownership of securities2026-06-01SEC
2026-06-018-KCurrent report2026-05-27SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-208-KCurrent report2026-05-18SEC
2026-04-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-29SCHEDULE 13GSEC
2026-04-29SCHEDULE 13GSEC
2026-04-298-KCurrent report2026-04-29SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1100161.09K2

Institutional holders

Manager% owned
ABSOLUTE INVESTMENT ADVISERS, LLC26.71%
BlackRock, Inc.16.01%
EARNEST PARTNERS LLC8.32%
VANGUARD PORTFOLIO MANAGEMENT LLC7.27%
FULLER & THALER ASSET MANAGEMENT, INC.5.25%
DIMENSIONAL FUND ADVISORS LP4.92%
STATE STREET CORP4.71%
VANGUARD CAPITAL MANAGEMENT LLC4.50%
BANK OF AMERICA CORP /DE/4.46%
SEI INVESTMENTS CO3.17%

Funds

Fund% owned
Calamos Market Neutral Income Fund91.82%
iShares Convertible Bond ETF44.45%
ABSOLUTE CONVERTIBLE ARBITRAGE FUND26.57%
iShares Core S&P Small-Cap ETF6.03%
American Beacon SSI Alternative Income Fund5.78%
Multi-Asset Strategy Fund5.57%
Undiscovered Managers Behavioral Value Fund4.38%
Multi-Strategy Income Fund3.37%
Calamos Short-Term Bond Fund3.34%
PACE Alternative Strategies Investments3.32%

OakChart. CNMD. Cached 15 minutes.